SK Biotek, a South Korean-owned pharmaceutical contract development company, has received planning permission to develop a manufacturing facility in Swords, Co Dublin, that could represent an investment of up to €35m. The development would see the demolishing of part of the original production building and the construction phase at the site is expected to take between 12 and 18 months. Read more here.
Recent Posts
- Dublin Port seeks planning permission for €1.1bn development
- Port of Cork to get €38.4m EU grant to develop offshore renewable energy facilities
- Plans lodged to extend DART services to Drogheda in ‘significant step forward’
- Irish housing completions forecast to be strongest among 19 European countries
- CIF welcomes increased capital spending in publication of the Summer Economic Statement
Recent Comments